查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390555

2023-2028 年脊椎生物製剂市场报告（按产品、手术类型、最终用户和地区划分）

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球脊椎生物製剂市场规模达到20亿美元。展望未来， IMARC Group预计到2028年市场规模将达到25亿美元，2022-2028年复合年增长率（CAGR）为3.79%。

脊椎生物製品是透过活跃的细胞过程改变周围环境的材料。它们促进生长和分化，并有助于损伤的修復和癒合。它们还减少了主要或额外外科手术的频率，并减少了软组织的损害。目前，多种脊椎生物製剂被用作传统治疗的替代品。例如，椎弓根螺钉和桿在脊椎融合手术中得到应用，以提供脊椎稳定，从而促进癒合。此外，不断的进步正在促进软骨和骨结构的修復和再生。

脊椎生物製剂市场趋势：

脊椎融合术被用作治疗脊椎创伤、肿瘤和退化性疾病的工具。然而，其不良结果可能会导致患者出现严重的併发症。这与患有急性和慢性疾病的人数显着增加相结合，成为积极影响全世界脊椎生物製剂使用的关键因素之一。脊椎生物製剂会影响细胞层面的融合，这有助于在治疗症状性畸形或不稳定时成功实现关节固定术。此外，全球老年人口数量增加，他们更容易受到肌肉骨骼疾病的影响。这加上骨科疾病的日益流行，正在刺激全球对脊椎生物製剂的需求。除此之外，对非手术程序不断增长的需求正在鼓励脊椎生物製剂在微创腰椎手术中的使用。脊椎生物製剂作为金属硬体的替代品以及个别天然骨移植物或异体移植物也越来越受到关注。此外，由于收入水准的提高，获得医疗服务的机会不断增加也促进了市场的成长。

本报告回答的关键问题

  • 全球脊椎生物製剂市场有多大？
  • 2023-2028年全球脊椎生物製品市场的预期成长率是多少？
  • 推动全球脊椎生物製品市场的关键因素是什么？
  • COVID-19 对全球脊椎生物製剂市场有何影响？
  • 基于该产品的全球脊椎生物製品市场的细分情况如何？
  • 根据手术类型，全球脊椎生物製品市场的细分情况如何？
  • 基于最终用户的全球脊椎生物製品市场的细分情况如何？
  • 全球脊椎生物製剂市场的关键区域有哪些？
  • 全球脊椎生物製剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球脊椎生物製品市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 同种异体脊椎移植物
    • 市场走向
    • 关键环节
      • 机械加工骨同种异体移植物
      • 去矿骨基质
    • 市场预测
  • 骨移植替代品
    • 市场走向
    • 关键环节
      • 骨形态发生蛋白
      • 合成骨移植物
    • 市场预测
  • 基于细胞的矩阵
    • 市场走向
    • 市场预测

第 7 章：依手术类型分類的市场细分

  • 开放式脊椎手术
    • 市场走向
    • 市场预测
  • 微创脊椎手术
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 门诊护理中心
    • 市场走向
    • 市场预测
  • 脊椎手术中心
    • 市场走向
    • 市场预测
  • 骨科诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Arthrex Inc
    • Alphatec Holdings Inc.
    • Exactech Inc
    • Johnson & Johnson
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Stryker Corporation
    • Wright Medical Group NV
    • Zimmer Biomet
Product Code: SR112023A4333

Abstract

The global spine biologics market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 3.79% during 2022-2028.

Spine biologics are materials that alter the surrounding environment through active cellular processes. They promote growth and differentiation and aid in the repair and healing of an injury. They also reduce the frequency of primary or additional surgical procedures and decrease the disruption of soft tissue. At present, a wide variety of spine biologics are used as an alternative to conventional treatments. For instance, pedicle screws and rods find application in a spine fusion procedure to provide spinal stabilization, thereby promoting healing. Moreover, continuous advancements are promoting the repair and regeneration of cartilaginous and bony structures.

Spine Biologics Market Trends:

Spine fusion is utilized as a tool in the treatment of spine trauma, tumors, and degenerative disorders. However, its poor outcomes can lead to serious complications among patients. This, in confluence with a significant increase in the number of individuals with acute and chronic conditions represents one of the key factors positively influencing the use of spine biologics around the world. Spine biologics impact fusion at the cellular level, which helps achieve successful arthrodesis in the treatment of symptomatic deformity or instability. Moreover, there is a rise in the geriatric population globally, which is more susceptible to musculoskeletal conditions. This, along with the growing prevalence of orthopedic conditions, is catalyzing the demand for spine biologics worldwide. Apart from this, the escalating demand for non-surgical procedures is encouraging the use of spinal biologics in minimally invasive lumbar surgeries. Spine biologics are also gaining traction as a replacement for metal hardware and in individual natural bone grafts or allografts. Furthermore, the growing access to healthcare services on account of inflating income levels is contributing to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global spine biologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, surgery type and end user.

Breakup by Product:

Spinal Allografts

Machined Bones Allograft

Demineralized Bone Matrix

Bone Graft Substitutes

Bone Morphogenetic Proteins

Synthetic Bone Grafts

Cell Based Matrix

Breakup by Surgery Type:

Open Spine Surgery

Minimally Invasive Spine Surgery

Breakup by End User:

Hospitals

Ambulatory Care Centers

Spinal Surgery Centers

Orthopedic Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Key Questions Answered in This Report

  • 1. How big is the global spine biologics market?
  • 2. What is the expected growth rate of the global spine biologics market during 2023-2028?
  • 3. What are the key factors driving the global spine biologics market?
  • 4. What has been the impact of COVID-19 on the global spine biologics market?
  • 5. What is the breakup of the global spine biologics market based on the product?
  • 6. What is the breakup of the global spine biologics market based on the surgery type?
  • 7. What is the breakup of the global spine biologics market based on the end user?
  • 8. What are the key regions in the global spine biologics market?
  • 9. Who are the key players/companies in the global spine biologics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Spine Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Spinal Allografts
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Machined Bones Allograft
      • 6.1.2.2 Demineralized Bone Matrix
    • 6.1.3 Market Forecast
  • 6.2 Bone Graft Substitutes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bone Morphogenetic Proteins
      • 6.2.2.2 Synthetic Bone Grafts
    • 6.2.3 Market Forecast
  • 6.3 Cell Based Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Surgery Type

  • 7.1 Open Spine Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Minimally Invasive Spine Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Spinal Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Orthopedic Clinics
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arthrex Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Alphatec Holdings Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Exactech Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Medtronic plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 NuVasive Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Orthofix Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Stryker Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Wright Medical Group N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Zimmer Biomet
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Spine Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Spine Biologics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Spine Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Spine Biologics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Spine Biologics Market: Breakup by Surgery Type (in %), 2022
  • Figure 6: Global: Spine Biologics Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Spine Biologics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Spine Biologics (Spinal Allografts) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Spine Biologics (Spinal Allografts) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Spine Biologics (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Spine Biologics (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Spine Biologics (Cell Based Matrix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Spine Biologics (Cell Based Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Spine Biologics (Open Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Spine Biologics (Open Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Spine Biologics (Minimally Invasive Spine Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Spine Biologics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Spine Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Spine Biologics (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Spine Biologics (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Spine Biologics (Spinal Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Spine Biologics (Spinal Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Spine Biologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Spine Biologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Spine Biologics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Spine Biologics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Spine Biologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Spine Biologics Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Spine Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Spine Biologics Industry: SWOT Analysis
  • Figure 78: Global: Spine Biologics Industry: Value Chain Analysis
  • Figure 79: Global: Spine Biologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Spine Biologics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Spine Biologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Spine Biologics Market Forecast: Breakup by Surgery Type (in Million US$), 2023-2028
  • Table 4: Global: Spine Biologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Spine Biologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Spine Biologics Market: Competitive Structure
  • Table 7: Global: Spine Biologics Market: Key Players